FindTrial
Sign In

The value of peripheral blood MUC2 in evaluating intestinal barrier function in patients with acute pancreatitis

The value of peripheral blood MUC2 in evaluating intestinal barrier function in patients with acute pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023792
Enrollment
Unknown
Registered
2019-06-12
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis

Interventions

Normal control group:None
MAP group:None
MSAP group:None
SAP group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. More than 18 years old; 2. Willing to participate in the Research and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. The diagnosis of AP is not clear; 2. History of chronic intestinal diseases; 3. After colectomy; 4. History of recurrent AP; 5. Unwilling to participate in the Research or sign informed consent.

Design outcomes

Primary

MeasureTime frame
Mucin 2;—

Secondary

MeasureTime frame
Endotoxin;Diamine oxidase;Fatty acid binding protein;D-lactic acid;—

Countries

China

Contacts

Public ContactWang Chunhui

West China Hospital, Sichuan University

wangch@scu.edu.cn+86 18980602216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026